Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Beta-blocker Uptitration with CRT in Heart Failure
NCT00433043Phase 4Terminated
- Sponsor
- St. Luke's-Roosevelt Hospital Center
- Start
- Jan 2007
- Primary completion
- May 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of carvedilol and metoprolol in heart failure (HF) (2 arms), sponsored by St. Luke's-Roosevelt Hospital Center. Primary endpoint: Left Ventricular End Systolic Volume Index Change at 6 months. Started Jan 2007; status: terminated.
02
Drugs
carvedilolmetoprolol
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00433043.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00433043.